{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:30:48Z","timestamp":1791570648039,"version":"4.3.4"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:00:00Z","timestamp":1696204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:00:00Z","timestamp":1696204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500522"],"award-info":[{"award-number":["81500522"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2020YFS0090, 2020YFS0046"],"award-info":[{"award-number":["2020YFS0090, 2020YFS0046"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cadre Health Research Project of Sichuan Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1038\/s41391-023-00729-4","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T07:01:52Z","timestamp":1696230112000},"page":"212-221","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Transperineal magnetic resonance imaging targeted biopsy versus transrectal route in the detection of prostate cancer: a systematic review and meta-analysis"],"prefix":"10.1038","volume":"27","author":[{"given":"Qiyou","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chichen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianhai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2220-8315","authenticated-orcid":false,"given":"Zhenhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3955-150X","authenticated-orcid":false,"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yige","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2336-9161","authenticated-orcid":false,"given":"Qiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,2]]},"reference":[{"key":"729_CR1","first-page":"7","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA: a cancer J clinicians. 2019;69:7\u201334.","journal-title":"CA: a cancer J clinicians"},{"key":"729_CR2","doi-asserted-by":"publisher","first-page":"5160","DOI":"10.1002\/cncr.31026","volume":"123","author":"CB Steele","year":"2017","unstructured":"Steele CB, Li J, Huang B, Weir HK. Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study. Cancer. 2017;123:5160\u201377.","journal-title":"Cancer"},{"key":"729_CR3","doi-asserted-by":"crossref","unstructured":"Siegel RL, Miller KD, Jemal A Cancer statistics, 2020. (2020);70:7-30.","DOI":"10.3322\/caac.21590"},{"key":"729_CR4","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1093\/jncimonographs\/lgs038","volume":"2012","author":"WM Hilton","year":"2012","unstructured":"Hilton WM, Padalecki SS, Ankerst DP, Leach RJ, Thompson IM. Temporal changes in the clinical approach to diagnosing prostate cancer. J Natl Cancer Inst Monogr. 2012;2012:162\u20138.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"729_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1148\/radiol.2017152877","volume":"286","author":"S Borofsky","year":"2018","unstructured":"Borofsky S, George AK, Gaur S, Bernardo M, Greer MD, Mertan FV, et al. What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate. Radiology. 2018;286:186\u201395.","journal-title":"Radiology"},{"key":"729_CR6","doi-asserted-by":"publisher","first-page":"S245","DOI":"10.1016\/j.jacr.2017.02.026","volume":"14","author":"FV Coakley","year":"2017","unstructured":"Coakley FV, Oto A, Alexander LF, Allen BC, Davis BJ, Froemming AT, et al. ACR appropriateness criteria(\u00ae) prostate cancer-pretreatment detection, surveillance, and staging. J Am Coll Radiology: JACR. 2017;14:S245\u2013s57.","journal-title":"J Am Coll Radiology: JACR"},{"key":"729_CR7","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.eururo.2014.08.079","volume":"67","author":"JD Le","year":"2015","unstructured":"Le JD, Tan N, Shkolyar E, Lu DY, Kwan L, Marks LS, et al. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology. Eur Urol. 2015;67:569\u201376.","journal-title":"Eur Urol"},{"key":"729_CR8","unstructured":"AsTRALDI AJUCR. Diagnosis of cancer of the prostate: biopsy by rectal route. 1937;41:421."},{"key":"729_CR9","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S0022-5347(17)38663-9","volume":"142","author":"KK Hodge","year":"1989","unstructured":"Hodge KK, McNeal JE, Stamey TA. Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J Urol. 1989;142:66\u201370.","journal-title":"J Urol"},{"key":"729_CR10","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.21037\/tau.2019.09.37","volume":"9","author":"A Moe","year":"2020","unstructured":"Moe A, Hayne D. Transrectal ultrasound biopsy of the prostate: does it still have a role in prostate cancer diagnosis? Transl Androl Urol. 2020;9:3018\u201324.","journal-title":"Transl Androl Urol"},{"key":"729_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.juro.2014.07.086","volume":"193","author":"F Bruy\u00e8re","year":"2015","unstructured":"Bruy\u00e8re F, Malavaud S, Bertrand P, Decock A, Cariou G, Doublet JD, et al. Prosbiotate: a multicenter, prospective analysis of infectious complications after prostate biopsy. J Urol. 2015;193:145\u201350.","journal-title":"J Urol"},{"key":"729_CR12","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.eururo.2012.04.044","volume":"62","author":"A Carignan","year":"2012","unstructured":"Carignan A, Roussy JF, Lapointe V, Valiquette L, Sabbagh R, P\u00e9pin J. Increasing risk of infectious complications after transrectal ultrasound-guided prostate biopsies: time to reassess antimicrobial prophylaxis? Eur Urol. 2012;62:453\u20139.","journal-title":"Eur Urol"},{"key":"729_CR13","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.21037\/tau.2019.12.40","volume":"9","author":"A Thomson","year":"2020","unstructured":"Thomson A, Li M, Grummet J, Sengupta S. Transperineal prostate biopsy: a review of technique. Transl Androl Urol. 2020;9:3009\u201317.","journal-title":"Transl Androl Urol"},{"key":"729_CR14","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1097\/JU.0000000000000156","volume":"201","author":"V Stefanova","year":"2019","unstructured":"Stefanova V, Buckley R, Flax S, Spevack L, Hajek D, Tunis A, et al. Transperineal prostate biopsies using local anesthesia: experience with 1,287 patients. prostate cancer detection rate, complications and patient tolerability. J Urol. 2019;201:1121\u20136.","journal-title":"J Urol"},{"key":"729_CR15","doi-asserted-by":"publisher","first-page":"23322","DOI":"10.18632\/oncotarget.15056","volume":"8","author":"J Xue","year":"2017","unstructured":"Xue J, Qin Z, Cai H, Zhang C, Li X, Xu W, et al. Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer: a meta-analysis and trial sequential analysis. Oncotarget. 2017;8:23322\u201336.","journal-title":"Oncotarget"},{"key":"729_CR16","first-page":"19","volume":"20","author":"VM Skouteris","year":"2018","unstructured":"Skouteris VM, Crawford ED, Mouraviev V, Arangua P, Metsinis MP, Skouteris M, et al. Transrectal ultrasound-guided versus transperineal mapping prostate biopsy: complication comparison. Rev Urol. 2018;20:19\u201325.","journal-title":"Rev Urol"},{"key":"729_CR17","doi-asserted-by":"publisher","first-page":"e860","DOI":"10.1016\/j.clgc.2019.05.006","volume":"17","author":"X Tu","year":"2019","unstructured":"Tu X, Liu Z, Chang T, Qiu S, Xu H, Bao Y, et al. Transperineal magnetic resonance imaging-targeted biopsy may perform better than transrectal route in the detection of clinically significant prostate cancer: systematic review and meta-analysis. Clin Genitourin Cancer. 2019;17:e860\u2013e70.","journal-title":"Clin Genitourin Cancer"},{"key":"729_CR18","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.euo.2020.12.012","volume":"4","author":"BP Rai","year":"2021","unstructured":"Rai BP, Mayerhofer C, Somani BK, Kallidonis P, Nagele U, Tokas T. Magnetic resonance imaging\/ultrasound fusion-guided transperineal versus magnetic resonance imaging\/ultrasound fusion-guided transrectal prostate biopsy-a systematic review. Eur Urol Oncol. 2021;4:904\u201313.","journal-title":"Eur Urol Oncol"},{"key":"729_CR19","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1016\/j.urolonc.2020.04.005","volume":"38","author":"LM Loy","year":"2020","unstructured":"Loy LM, Lim GH, Leow JJ, Lee CH, Tan TW, Tan CH. A systematic review and meta-analysis of magnetic resonance imaging and ultrasound guided fusion biopsy of prostate for cancer detection-Comparing transrectal with transperineal approaches. Urol Oncol. 2020;38:650\u201360.","journal-title":"Urol Oncol"},{"key":"729_CR20","first-page":"i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Clin Res ed). 2016;355:i4919.","journal-title":"BMJ (Clin Res ed)"},{"key":"729_CR21","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ (Clin Res ed). 2011;343:d5928.","journal-title":"BMJ (Clin Res ed)"},{"key":"729_CR22","doi-asserted-by":"crossref","unstructured":"McGuinness LA, Higgins JPT Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments. Research Synthesis Methods. (2020);n\/a.","DOI":"10.1002\/jrsm.1411"},{"key":"729_CR23","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/j.eururo.2018.11.040","volume":"75","author":"O Wegelin","year":"2019","unstructured":"Wegelin O, Exterkate L, van der Leest M, Kummer JA, Vreuls W, de Bruin PC, et al. The FUTURE trial: a multicenter randomised controlled trial on target biopsy techniques based on magnetic resonance imaging in the diagnosis of prostate cancer in patients with prior negative biopsies. Eur Urol. 2019;75:582\u201390.","journal-title":"Eur Urol"},{"key":"729_CR24","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41391-020-0205-7","volume":"23","author":"Y Ber","year":"2020","unstructured":"Ber Y, Segal N, Tamir S, Benjaminov O, Yakimov M, Sela S, et al. A noninferiority within-person study comparing the accuracy of transperineal to transrectal MRI-US fusion biopsy for prostate-cancer detection. Prostate Cancer Prostatic Dis. 2020;23:449\u201356.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"729_CR25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.5152\/tud.2022.21248","volume":"48","author":"A El-Achkar","year":"2022","unstructured":"El-Achkar A, Abou Heidar N, Labban M, Al-Moussawy M, Moukaddem H, Nasr R, et al. MRI\/US fusion transperineal versus transrectral biopsy of prostate cancer: Outcomes and complication rates, a tertiary medical center experience in the Middle East. Turkish J Urol. 2022;48:98\u2013105.","journal-title":"Turkish J Urol"},{"key":"729_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-022-01011-w","volume":"22","author":"PF Hsieh","year":"2022","unstructured":"Hsieh PF, Chang TY, Lin WC, Chang H, Chang CH, Huang CP, et al. A comparative study of transperineal software-assisted magnetic resonance\/ultrasound fusion biopsy and transrectal cognitive fusion biopsy of the prostate. BMC Urol. 2022;22:72.","journal-title":"BMC Urol"},{"key":"729_CR27","doi-asserted-by":"publisher","first-page":"e953","DOI":"10.1016\/j.clgc.2018.03.013","volume":"16","author":"S Kaufmann","year":"2018","unstructured":"Kaufmann S, Russo GI, Thaiss W, Notohamiprodjo M, Bamberg F, Bedke J, et al. Cognitive versus software-assisted registration: development of a new nomogram predicting prostate cancer at MRI-targeted biopsies. Clin Genitourin Cancer. 2018;16:e953\u2013e60.","journal-title":"Clin Genitourin Cancer"},{"key":"729_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/pros.24288","volume":"82","author":"MY Koparal","year":"2022","unstructured":"Koparal MY, S\u00f6zen TS, Kar\u015f\u0131yakal\u0131 N, Aslan G, Akdo\u011fan B, \u015eahin B, et al. Comparison of transperineal and transrectal targeted prostate biopsy using Mahalanobis distance matching within propensity score caliper method: A multicenter study of Turkish Urooncology Association. Prostate. 2022;82:425\u201332.","journal-title":"Prostate"},{"key":"729_CR29","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.prnil.2020.10.001","volume":"9","author":"JL Marenco Jimenez","year":"2021","unstructured":"Marenco Jimenez JL, Claps F, Ram\u00f3n-Borja JC, Mascar\u00f3s Martinez JM, Gutierrez AW, Lozano \u00c1GF, et al. Rebiopsy rate after transperineal or transrectal prostate biopsy. Prostate Int. 2021;9:78\u201381.","journal-title":"Prostate Int"},{"key":"729_CR30","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.clgc.2016.07.007","volume":"15","author":"P Pepe","year":"2017","unstructured":"Pepe P, Garufi A, Priolo G, Pennisi M. Transperineal Versus Transrectal MRI\/TRUS fusion targeted biopsy: detection rate of clinically significant prostate cancer. Clin Genitourin Cancer. 2017;15:e33\u2013e6.","journal-title":"Clin Genitourin Cancer"},{"key":"729_CR31","first-page":"3291","volume":"37","author":"P Pepe","year":"2017","unstructured":"Pepe P, Garufi A, Priolo GD, Pennisi M. Multiparametric MRI\/TRUS fusion prostate biopsy: advantages of a transperineal approach. Anticancer Res. 2017;37:3291\u20134.","journal-title":"Anticancer Res"},{"key":"729_CR32","doi-asserted-by":"publisher","first-page":"649","DOI":"10.15537\/smj.2021.42.6.20200771","volume":"42","author":"D Rabah","year":"2021","unstructured":"Rabah D, Al-Taweel W, Khan F, Arafa M, Mehmood S, Mokhtar A, et al. Transperineal versus transrectal multi-parametric magnetic resonance imaging fusion targeted prostate biopsy. Saudi Med J. 2021;42:649\u201354.","journal-title":"Saudi Med J"},{"key":"729_CR33","doi-asserted-by":"publisher","first-page":"2176471","DOI":"10.1155\/2017\/2176471","volume":"2017","author":"S Tewes","year":"2017","unstructured":"Tewes S, Peters I, Tiemeyer A, Peperhove M, Hartung D, Pertschy S, et al. Evaluation of MRI\/Ultrasound Fusion-Guided Prostate Biopsy Using Transrectal and Transperineal Approaches. BioMed Res Int. 2017;2017:2176471.","journal-title":"BioMed Res Int"},{"key":"729_CR34","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1080\/21681805.2021.1981995","volume":"55","author":"H Ugge","year":"2021","unstructured":"Ugge H, Jarl S, Georgouleas P, Andersson SO, Sundqvist P, Frey J. Diagnostic outcomes from transrectal and transperineal prostate biopsies\u2014experiences from a Swedish tertiary care Centre. Scand J Urol. 2021;55:434\u201340.","journal-title":"Scand J Urol"},{"key":"729_CR35","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.urology.2020.07.072","volume":"146","author":"JS Winoker","year":"2020","unstructured":"Winoker JS, Wajswol E, Falagario U, Maritini A, Moshier E, Voutsinas N, et al. Transperineal versus transrectal targeted biopsy with use of electromagnetically-tracked MR\/US Fusion Guidance Platform for the Detection of Clinically Significant Prostate Cancer. Urology. 2020;146:278\u201386.","journal-title":"Urology"},{"key":"729_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/bju.13971","volume":"120","author":"AJ Yaxley","year":"2017","unstructured":"Yaxley AJ, Yaxley JW, Thangasamy IA, Ballard E, Pokorny MR. Comparison between target magnetic resonance imaging (MRI) in-gantry and cognitively directed transperineal or transrectal-guided prostate biopsies for Prostate Imaging-Reporting and Data System (PI-RADS) 3-5 MRI lesions. BJU Int. 2017;120:43\u201350.","journal-title":"BJU Int"},{"key":"729_CR37","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1097\/JU.0000000000002802","volume":"208","author":"F Zattoni","year":"2022","unstructured":"Zattoni F, Marra G, Kasivisvanathan V, Grummet J, Nandurkar R, Ploussard G, et al. The detection of prostate cancer with magnetic resonance imaging-targeted prostate biopsies is superior with the transperineal vs the transrectal approach. a european association of urology-young academic urologists prostate cancer working group multi-institutional study. J Urol. 2022;208:830\u20137.","journal-title":"J Urol"},{"key":"729_CR38","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.euo.2019.08.007","volume":"2","author":"O Wegelin","year":"2019","unstructured":"Wegelin O, Exterkate L, van der Leest M, Kelder JC, Bosch J, Barentsz JO, et al. Complications and adverse events of three magnetic resonance imaging-based target biopsy techniques in the diagnosis of prostate cancer among men with prior negative biopsies: results from the FUTURE trial, a multicentre randomised controlled trial. Eur Urol Oncol. 2019;2:617\u201324.","journal-title":"Eur Urol Oncol"},{"key":"729_CR39","doi-asserted-by":"publisher","first-page":"110","DOI":"10.4103\/1119-3077.146991","volume":"18","author":"EI Udeh","year":"2015","unstructured":"Udeh EI, Amu OC, Nnabugwu II, Ozoemena O. Transperineal versus transrectal prostate biopsy: our findings in a tertiary health institution. Niger J Clin Pract. 2015;18:110\u20134.","journal-title":"Niger J Clin Pract"},{"key":"729_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/srep16089","volume":"5","author":"LH Guo","year":"2015","unstructured":"Guo LH, Wu R, Xu HX, Xu JM, Wu J, Wang S, et al. Comparison between ultrasound guided transperineal and transrectal prostate biopsy: a prospective, randomized, and controlled trial. Sci Rep. 2015;5:16089.","journal-title":"Sci Rep"},{"key":"729_CR41","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/JU.0000000000001399","volume":"205","author":"B Pradere","year":"2021","unstructured":"Pradere B, Veeratterapillay R, Dimitropoulos K, Yuan Y, Omar MI, MacLennan S, et al. Nonantibiotic strategies for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis. J Urol. 2021;205:653\u201363.","journal-title":"J Urol"},{"key":"729_CR42","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.eururo.2015.06.008","volume":"68","author":"C Arsov","year":"2015","unstructured":"Arsov C, Rabenalt R, Blondin D, Quentin M, Hiester A, Godehardt E, et al. Prospective randomized trial comparing magnetic resonance imaging (MRI)-guided in-bore biopsy to MRI-ultrasound fusion and transrectal ultrasound-guided prostate biopsy in patients with prior negative biopsies. Eur Urol. 2015;68:713\u201320.","journal-title":"Eur Urol"},{"key":"729_CR43","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00345-018-2189-7","volume":"36","author":"S Kaufmann","year":"2018","unstructured":"Kaufmann S, Russo GI, Bamberg F, L\u00f6we L, Morgia G, Nikolaou K, et al. Prostate cancer detection in patients with prior negative biopsy undergoing cognitive-, robotic- or in-bore MRI target biopsy. World J Urol. 2018;36:761\u20138.","journal-title":"World J Urol"},{"key":"729_CR44","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1148\/radiol.13121501","volume":"268","author":"P Puech","year":"2013","unstructured":"Puech P, Rouvi\u00e8re O, Renard-Penna R, Villers A, Devos P, Colombel M, et al. Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy-prospective multicenter study. Radiology. 2013;268:461\u20139.","journal-title":"Radiology"},{"key":"729_CR45","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.eururo.2013.10.048","volume":"66","author":"JS Wysock","year":"2014","unstructured":"Wysock JS, Rosenkrantz AB, Huang WC, Stifelman MD, Lepor H, Deng FM, et al. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. Eur Urol. 2014;66:343\u201351.","journal-title":"Eur Urol"},{"key":"729_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5124-9","volume":"18","author":"Z Mai","year":"2018","unstructured":"Mai Z, Zhou Z, Yan W, Xiao Y, Zhou Y, Liang Z, et al. The transverse and vertical distribution of prostate cancer in biopsy and radical prostatectomy specimens. BMC cancer. 2018;18:1205.","journal-title":"BMC cancer"},{"key":"729_CR47","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.eururo.2016.12.006","volume":"71","author":"MG Schouten","year":"2017","unstructured":"Schouten MG, van der Leest M, Pokorny M, Hoogenboom M, Barentsz JO, Thompson LC, et al. Why and Where do We Miss Significant Prostate Cancer with Multi-parametric Magnetic Resonance Imaging followed by Magnetic Resonance-guided and Transrectal Ultrasound-guided Biopsy in Biopsy-na\u00efve Men? Eur Urol. 2017;71:896\u2013903.","journal-title":"Eur Urol"},{"key":"729_CR48","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.eururo.2017.01.010","volume":"71","author":"G Giannarini","year":"2017","unstructured":"Giannarini G, Crestani A, Rossanese M, Ficarra V. Multiparametric magnetic resonance imaging targeted biopsy for early detection of prostate cancer: all that glitters is not gold! Eur Urol. 2017;71:904\u20136.","journal-title":"Eur Urol"},{"key":"729_CR49","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/JU.0000000000002182","volume":"207","author":"C Williams","year":"2022","unstructured":"Williams C, Ahdoot M, Daneshvar MA, Hague C, Wilbur AR, Gomella PT, et al. Why does magnetic resonance imaging-targeted biopsy miss clinically significant cancer? J Urol. 2022;207:95\u2013107.","journal-title":"J Urol"},{"key":"729_CR50","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1089\/end.2017.0694","volume":"32","author":"D Halstuch","year":"2018","unstructured":"Halstuch D, Baniel J, Lifshitz D, Sela S, Ber Y, Margel D. Assessment of needle tip deflection during transrectal guided prostate biopsy: implications for targeted biopsies. J Endourol. 2018;32:252\u20136.","journal-title":"J Endourol"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41391-023-00729-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-023-00729-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41391-023-00729-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,15]],"date-time":"2024-05-15T11:04:32Z","timestamp":1715771072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-023-00729-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["729"],"URL":"https:\/\/doi.org\/10.1038\/s41391-023-00729-4","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,2]]},"assertion":[{"value":"19 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}